Oct. 24 Glonhui | Barclays: Lowered CVS Health's target price from $82 to $75, maintaining a "shareholding" rating. (Glonhui)
巴克莱下调CVS Health目标价至75美元
Barclays lowers CVS Health's target price to $75.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated